Luramist reviews – is Luramist effective?
The medical field has made a lot of advanced researches in everything that the human world is facing in the name of Disease. Here the term Luramist is again a medical term that describes the research made by the research scholars in the female sexual; dysfunction found in the female body.
In general, Luramist is an easy to use model of equipment, small in size, a hand held transdermal spray containing the Testosterone and a proprietary skin penetration enhancer. This has enhanced or made a gradual increase in the increasing of the number of satisfying sexual events in pre-menopausal patients with HSDD. This has made a significant growth in the research module a different answer that has made them to make their concentration again towards this point.
Now owned by VIVUS, Luramist is an interesting approach to Testosterone delivery hoping to develop and commercialize what they call a MDTS or Metered Dose Transdermal Spray. Being developed and studied for a treatment in women experiencing low sexual desire or Hypo Sexual Desire Disorder this is another solution to keep your eyes on.
With the promise of being very small and extremely simple to use the product may put up a run in the industry if made available in the US as the studies have shown positive results in its ability to alter the number of sexual encounters in comparison with a placebo group.
The details study made by the Australian group of researches here has showed a significant improvement. Their first phase of research to evaluate the pharmacokinetic profile of the Luramist and to determine the optimal physiologic replacement doses which provided a demonstration that the MDTS (Metered Dose Transdermal Spray) has the capacity of providing a sustained or a continued delivery of the testosterone for a period of about a day and also supports in restoring the physiological blood levels to the mid to high normal range in a woman with a low testosterone.
As a result of this they have made further analysis in the study of the Luramist, they have reached yet another point where they have arrived with a significant improvement in the number of support sexual events in pre-menopausal patients with HSDD. The research group has made this study with a particular number of women to find a statistical review and also a research in the study of finding the actual root cause in finding the result for the issue the women are facing in their life.